S&P 500 7718.60 -0.38%
NASDAQ 26506.99 -0.29%
TASI 11024.73 -0.40%
Oil (WTI) 91.48 +0.00%
Oil (Brent) 96.28 +0.00%
VIX 15.30 +5.30%
Gold 4476.60 +0.00%
USD/SAR 3.76 +0.02%

Moderna, Inc.

MRNA · Healthcare · · USD
145.55 USD
0.00 (-2.23%)
● Updated 2026-09-07 20:35 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score STRONG BUY Mid-term (Position)

87
/ 100
Technical 100
Trend & RS 100
Momentum 100
Fundamental 61
Macro 64
Liquidity 52
ComponentScoreWeight
Technical 100.0 20%
Trend & RS 100.0 30%
Momentum 100.0 15%
Fundamental 61.1 10%
Macro 64.4 20%
Liquidity 52.4 5%

Trade Setup

Entry 145.55
Stop Loss 118.17 (18.8%)
Target 1 (1:1) 172.93 (+18.8%)
Target 2 (2:1) 200.31 (+37.6%)
ATR(14) 13.69 (9.4%)
Risk per Share 27.38
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 14.8 -1.41
Momentum 100.0 +2.00
Quality 17.1 -1.32
Composite 44.0

Quality Scores

Piotroski F-Score 2 /9 — Weak
✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✗
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score 28.03 — Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Overvalued

MetricStockSectorvs Peers
P/E Ratio N/A 22.0 Inline
P/B Ratio 8.6 4.0 Above

Comparing against Healthcare median multiples.

Trading at a premium to sector peers — verify growth justifies premium.

Position Sizing — Kelly Criterion

4.5%
Recommended Size
55.08%
Full Kelly
27.54%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 87/100. Estimated win rate 66%, avg win 10.2%, avg loss 3.3%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

4
Bullish Signals
0
Bearish Signals
63.19
RSI(14)
21.9685
MACD

Relative Strength (RS) IMPROVING

99
/ 99
RS Rating
✓ O'Neil PASS (≥80)
RS vs SPY ↑ RISING (+202.1% vs SPY 3M)
RS vs Sector OUTPERFORMING (Healthcare)
RS New High No (12d since high)
Sector Outperformance +199.0% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

IndicatorValueSignal
Rsi 63.19 NEUTRAL
Macd 21.9685 BULLISH
Ma Cross 85.5 / 54.82 GOLDEN CROSS
Trend Short ABOVE SMA50
Trend Long ABOVE SMA200
Bollinger MIDDLE
Volume 0.45x LOW

Key Levels

LevelPrice
52-Week High176.66
Bollinger Upper203.0
SMA(200)54.82
SMA(50)85.5
SMA(20)117.96
Current Price145.55
Bollinger Lower32.93
52-Week Low22.28
ATR(14)13.69

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION A Confidence
33%
Selling Climax Buying Climax
Acc: 2.0  |  Dist: 2.0  |  Markup: 2.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-08-31 Normal 0.55x Normal bar — no special VSA pattern
2026-09-01 Normal 0.77x Normal bar — no special VSA pattern
2026-09-02 Normal 0.49x Normal bar — no special VSA pattern
2026-09-03 No Supply 0.4x Low volume, narrow spread, firm close — no selling pressure
2026-09-04 Normal 0.45x Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

LineValueStatus
Tenkan-sen (9) 147.35 Above Kijun
Kijun-sen (26) 114.66 Base line
Senkou A 131.00 Leading span A
Senkou B 114.66 Leading span B
Cloud 114.66 – 131.00 Bullish (Green)
Price vs Cloud 145.55 Above Cloud
Chikou Span 54.82 Bullish
Alignment Score 4/4 BULLISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BULLISH FADING
BB: 32.93 – 203.0  |  KC: 92.62 – 143.3

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Regular Bullish RSI 22

Anchored VWAP

VWAP: 75.89 Anchor: 2025-11-21 (52w Low) ABOVE AVWAP +91.8%

Heikin-Ashi Trend

WEAKLY BULLISH Full data via /api/advanced/MRNA

Valuation

MetricValue
Market Cap58.11B
P/E (TTM)N/A
Forward P/EN/A
P/B8.59
EPS-7.98

Financial Health

MetricValue
Revenue Growth2.1%
Profit Margin-1.4%
ROE-39.0%
Debt/Equity19.04
Current Ratio2.29
Dividend YieldN/A
Payout RatioN/A
Beta1.11

Trading Data

145.55
Open
145.55
Day High
145.55
Day Low
14.97M
Volume (1.0x avg)

Recent News (8)

How Is Moderna's Stock Performance Compared to Other Healthcare Stocks
Barchart · 2026-09-07
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
MarketBeat · 2026-09-06
If You'd Invested in Moderna (MRNA) Stock 5 Years Ago, Here's How Much You'd Have Today (Hint: You'd Be Disappointed -- But Not If You Bought It 1 Year Ago.)
Motley Fool · 2026-09-06
What Does Moderna (MRNA) Bird Flu Phase 3 Trial Mean For Its Growth?
Simply Wall St. · 2026-09-05
Is Moderna (MRNA) Fully Valued After Its New 2032 Convertible Notes?
Simply Wall St. · 2026-09-05
Moderna (MRNA) Stock Looks Expensive On Sales After A Very Large Run
Simply Wall St. · 2026-09-04
Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense
Barrons.com · 2026-09-04
Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run?
Motley Fool · 2026-09-04

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —